# Evaluation of Type 2 Diabetes Treatment

> **NCT03164187** · — · COMPLETED · sponsor: **Servier Affaires Médicales** · enrollment: 105 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** Diabeton 60 MR

## Key facts

- **NCT ID:** NCT03164187
- **Lead sponsor:** Servier Affaires Médicales
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2017-05-15
- **Final completion:** 2017-06-10
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164187, "Evaluation of Type 2 Diabetes Treatment". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03164187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*